TYT: "The pharmaceutical company behind OxyContin is paying dozens of clinical sites to document the effects of the highly addictive painkiller on children as part of an effort to secure a Food and Drug Administration approval to label the drug for use by kids ages six and up, according to a report published by The Daily.
Though Purdue Pharma insists it is conducting the trials to ensure the safety of children currently being prescribed OxyContin "off-label" by doctors, some, including three physicians involved in the trials, said the company is more concerned about the impending expiration of the drug's patent, and is hoping to receive a six-month extension from the FDA..."* Ana Kasparian and Cenk Uygur discuss on The Young Turks.
Load Comments...
Discuss...
Enable JavaScript to submit a comment.